1. Home
  2. JYNT vs BDSX Comparison

JYNT vs BDSX Comparison

Compare JYNT & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$8.87

Market Cap

120.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$9.96

Market Cap

107.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JYNT
BDSX
Founded
2010
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Precision Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.7M
107.5M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
JYNT
BDSX
Price
$8.87
$9.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$17.00
$32.50
AVG Volume (30 Days)
28.5K
48.1K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
133.93
N/A
EPS
0.19
N/A
Revenue
$117,696,356.00
$88,499,000.00
Revenue This Year
$12.23
$25.26
Revenue Next Year
N/A
$19.15
P/E Ratio
$47.68
N/A
Revenue Growth
15.49
24.08
52 Week Low
$7.50
$0.25
52 Week High
$13.47
$20.21

Technical Indicators

Market Signals
Indicator
JYNT
BDSX
Relative Strength Index (RSI) 51.96 31.06
Support Level $8.01 $6.00
Resistance Level $9.05 $11.57
Average True Range (ATR) 0.33 1.01
MACD 0.01 -0.33
Stochastic Oscillator 39.77 10.92

Price Performance

Historical Comparison
JYNT
BDSX

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: